Definitive Healthcare Corp.
NASDAQ:DHMedical - Healthcare Information Services
+$0.01 today
- Market cap
- $143.60M
- Beta
- 1.33
- P/E (TTM)
- -0.5
- EPS (TTM)
- -$1.63
Volume 0.43M
Average 0.32M
DH EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Definitive Healthcare Corp.NASDAQ: DH
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA turns positive
Q1 FY2026 EBITDA was $8.41M, compared with -$149.73M a year earlier. Trailing-twelve-month EBITDA was $11.6M.
Context
- EBITDA amounted to 67.1% of revenue in FY2025, down 157.8 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $88.71M (+154.7%) for the fiscal year ending Dec 2026, a step up from the +71.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $8.41M+264.3% QoQ
- Last fiscal yearDec 2025
- -$162.15M+71.4% YoY
- LTMMar 2026
- $11.6M+101.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +105.6% | +160.3% | +54.7 pp |
| 1 year | +71.4% | +154.7% | +83.3 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (162.15M) USD
- Year-over-year change
- +71.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (162.15M) | +71.4% |
| FY2024 | 2024-12-31 | (567.24M) | -135.1% |
| FY2023 | 2023-12-31 | (241.23M) | -1019.8% |
| FY2022 | 2022-12-31 | 26.23M | +13.6% |
| FY2021 | 2021-12-31 | 23.08M | — |
EBITDA vs competitors
How DH compares with its peers on the latest reported figures
- DH's LTM Mar 2026 EBITDA of $11.6M is the 5th highest of the 10 companies compared; the peer median is -$66.08M.
- Its year-over-year change of +101.6% is the highest of 10, against a peer median of -26.5%.
- EBITDA amounts to 4.9% of revenue for DH, versus a peer median of 21.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $32.57M | -26.5% | -3.8% | 9.4% | |
| LTM Mar 2026 | $27.87M | -32.4% | -15.0% | 20.1% | |
| LTM Mar 2026 | $22.22M | -11.4% | +75.9% | 16.3% | |
| LTM Feb 2026 | $17.31M | +4.6% | -7.7% | 21.5% | |
| LTM Mar 2026 | $11.6M | +101.6% | — | 4.9% | |
| LTM Mar 2026 | -$66.08M | -31.0% | — | 81.4% | |
| LTM Mar 2026 | -$100.08M | +56.8% | — | 258.7% | |
| LTM Mar 2026 | -$153.62M | -5.2% | — | — | |
| LTM Mar 2026 | -$171.58M | -48.1% | — | — | |
| LTM Mar 2026 | -$276.76M | -6900.5% | — | 7060.9% | |
| Peer median (excluding DH) | -$66.08M | -26.5% | -5.8% | 21.5% | |
Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 166.15M | 222.65M | 251.42M | 252.2M | 241.52M |
| Cost of Revenue | 40.69M | 42.63M | 47.48M | 54.73M | 58.25M |
| Gross Profit | 125.47M | 180.03M | 203.93M | 197.47M | 183.28M |
| Gross Margin | 75.5% | 80.9% | 81.1% | 78.3% | 75.9% |
| Research & Development | 18.57M | 34.89M | 42.44M | 36.52M | 34.78M |
| Selling, General & Admin | 89.25M | 141.15M | 153.4M | 133.07M | 133.26M |
| Operating Expenses | 152.78M | 224.07M | 533.73M | 908.29M | 203.86M |
| Depreciation & Amortization | 59.95M | 56.9M | 51.75M | 51.67M | 35.82M |
| EBITDA | 23.08M | 26.23M | (241.23M) | (567.24M) | (162.15M) |
| EBITDA Margin | 13.9% | 11.8% | -95.9% | -224.9% | -67.1% |
| Operating Income | (27.32M) | (44.04M) | (329.8M) | (710.82M) | (20.58M) |
| Operating Margin | -16.4% | -19.8% | -131.2% | -281.8% | -8.5% |
| Interest Income | 29K | 2.79M | 13.64M | 14.59M | 6.95M |
| Interest Expense | 25.9M | 11.2M | 15.2M | 14.84M | 11.29M |
| Other Income / Expenses | (35.45M) | 2.17M | 21.62M | 77.08M | (188.67M) |
| Income Before Tax | (62.77M) | (41.88M) | (308.18M) | (633.75M) | (209.26M) |
| Pre-Tax Margin | -37.8% | -18.8% | -122.6% | -251.3% | -86.6% |
| Income Tax Expense | (443K) | (17.7M) | (18.55M) | (42.3M) | (9.96M) |
| Net Income | (51.91M) | (7.22M) | (202.39M) | (413.12M) | (138.93M) |
| Net Margin | -31.2% | -3.2% | -80.5% | -163.8% | -57.5% |
| EPS (Basic) | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| EPS (Diluted) | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| Weighted Avg Shares | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
| Weighted Avg Shares (Diluted) | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
Definitive Healthcare Corp.
NASDAQ:DH
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.